Nuzenio

Recursion Reports Second

Recursion Reports Second news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Recursion Pharmaceuticals (RXRX) Reported Q2 Revenue Pressure, Is The Valuation Gap Too Wide? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 05:45:46 GMT Recursion Pharmaceuticals (RXRX) director sells 30,000 shares in 10b5-1 plan - Stock TitanStock Titan · Thu, 06 Aug 2026 21:10:07 GMT Recursion Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreetAlphaStreet · Wed, 05 Aug 2026 16:57:36 GMT Recursion Pharmaceuticals stock opens with a gap up, upside probability set at 65% for the week - Traders UnionTraders Union · Wed, 05 Aug 2026 11:05:23 GMT Recursion Pharmaceuticals (NASDAQ: RXRX) gains Genentech milestone, highlights FAP drug progress - Stock TitanStock Titan · Wed, 05 Aug 2026 10:32:17 GMT Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 10:30:00 GMT Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules - marketscreener.commarketscreener.com · Fri, 31 Jul 2026 20:30:06 GMT Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 05:45:46 GMTRecursion Pharmaceuticals (RXRX) Reported Q2 Revenue Pressure, Is The Valuation Gap Too Wide? - simplywall.st

Thu, 06 Aug 2026 21:10:07 GMTRecursion Pharmaceuticals (RXRX) director sells 30,000 shares in 10b5-1 plan - Stock Titan

Wed, 05 Aug 2026 16:57:36 GMTRecursion Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreet

Wed, 05 Aug 2026 11:05:23 GMTRecursion Pharmaceuticals stock opens with a gap up, upside probability set at 65% for the week - Traders Union

Wed, 05 Aug 2026 10:32:17 GMTRecursion Pharmaceuticals (NASDAQ: RXRX) gains Genentech milestone, highlights FAP drug progress - Stock Titan

Wed, 05 Aug 2026 10:30:00 GMTRecursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program - Yahoo Finance

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

RXRX6 live mentions Recursion Pharmaceuticals5 live mentions Financial Results4 live mentions Recursion4 live mentions Pharmaceuticals3 live mentions Reported2 live mentions Revenue Pressure2 live mentions Is The Valuation2 live mentions Gap Too Wide2 live mentions Stock Titan Recursion2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Recursion Reports Second.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.